Free Webinars – Overview

See how Lonza can help you identify the right target, while develop the appropriate toxicity and immunogenicity testing and building the right in vitro models.

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.

Presented by Drug Discovery News.

Learn how mycoplasma detection by MycoAlert^® Assay can safeguard your cell cultures and enhance your research integrity.

In this webinar, learn about the negative effects of culturing cells in serum and the advantages of switching to serum-free cell culturing.

An Assessment of Cryopreservation Impact on T-Cell Activation and Phenotype.

This webinar provides you with tips and hints to start or improve your primary cell culture.

Learn about how the new Nucleofector^® Platform is used for large scale editing with CRISPR and the TcBuster™ transposon system.

Learn about two novel methods for the expansion of γδ T Cells and discover our data showcasing the methods’ suitability for clinical applications.

Watch our team demonstrate the 4D-Nucleofector^® LV Unit for efficient large-scale electroporation and learn about the technology’s benefits for ex vivo genetic modification in cell and gene therapy manufacturing. 

Watch this 60-min roundtable discussion and join our expert panel as they discuss challenges, promising tools, trends and the future of CAR-T therapies.

In this webinar, Walter Bagni shares Lonza's approach digitalizing our cell therapy manufacturing operations and the future plans for the MODA-ES^® System within Lonza.

Join leading cell therapy thought leaders as they share their insights and lessons learned on advancing therapies from bench to bedside, the challenges they face, and where in their view the fast-evolving cell therapy field is heading.

Presented by CAR-TCR Digital Week

Learn from Senior Scientist Jerome Jacques how Lonza's new TheraPEAK^® SfAAV^® Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

Learn about CRISPR from discovery to cell and gene therapies, covering topics such as finding therapeutic pathways or process development considerations for bringing gene edited therapies to the clinic.

Presented by GEN

Learn about the latest advances and outstanding challenges in the fast paced research environment of CARs with experts that bridge the lab and clinic.

Presented by Nature Biotechnology

Learn more about the most promising approaches to cancer immunotherapy.

Presented by Nature Immunology and Nature Reviews Immunology

Join our webinar to learn about reliable transfection methods for engineering human protein therapeutics.

Learn from Senior Scientist Jerome Jacques how Lonza's new TheraPEAK^® SfAAV^® Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

Learn about practical strategies to improve mRNA-based CAR T cell screening and selection.

Presented by Inside Scientific

Learn about how the new Nucleofector^® Platform is used for large scale editing with CRISPR and the TcBuster™ transposon system.

See how Lonza can help you identify the right target, while develop the appropriate toxicity and immunogenicity testing and building the right in vitro models.

Join us for this webinar to find out about the new CAR Finder technology to screen for best CARs.
 

Learn how you can use the 384-well Nucleofector^® System for phenotypic screens in complex cell models.

Join our webinar to learn about reliable transfection methods for engineering human protein therapeutics.

Learn about automated transformation of a gram-positive platform organism for strain construction.

Discover best practices, tips and tricks for genome editing of immune cells (such as primary T cells or NK cells) and learn about the impact of CRISPR on cell and gene therapy development and drug discovery.

Discover key considerations for CRISPR screening set-up and learn about the impact of CRISPR in drug discovery, e.g. for target identification.

Through a selection of four speaker sessions and a concluding panel discussion, you’ll discover latest transfection applications and receive tips and tricks from our experts.

Learn how to generate Knock-outs in myeloid cells and how to target microglial pathways for Alzheimer’s disease therapy.

Learn about CRISPR from discovery to cell and gene therapies, covering topics such as finding therapeutic pathways or process development considerations for bringing gene edited therapies to the clinic.

Presented by GEN

Over the last few years, CRISPR/Cas9 has emerged as the genome editing method of choice. Explore the full CRISPR potential and hear about best practices to achieve optimal delivery results.

Learn about strategies for using CRIPSR/Cas9 for curing genetic diseases, and the impact on next generation disease model systems and drug screening. 

Presented by GEN

Get useful transfection tips and learn what factors may impact your transfection results when using the Nucleofector^® Technology.

This webinar introduces the Nucleofector^® Technology as an efficient, convenient and cost-effective, non-viral alternative for iPSC generation. 

Learn about the latest advances and outstanding challenges in the fast paced research environment of CARs with experts that bridge the lab and clinic.

Presented by Nature Biotechnology

Learn how primary cells and optimized media systems can be the building blocks for developing the next generation of predictive in vitro ADMET solutions

In this talk, learn in vitro approaches to identify mechanisms of idiosyncratic drug-induced liver injury (IDILI) and emerging systems to investigate genetic risk factors.

Dr. Stephen Ferguson, a leading researcher at the National Institute of Environmental Health Sciences (NIEHS), discusses how liver cells assembled in 3D spheroids produce highly differentiated functionality and utility for toxicology screening.

With emphasis on sustainability and regulatory modernization, find out about insights and tools to adopt non-animal, in vitro testing strategies.

Register for an exclusive free webinar, exploring the latest developments in Chapter <86>, recombinant Factor C (rFC), and the sustainability of endotoxin testing.

Join our webinar to explore real-life case studies to ensure the safety of drug products using the Monocyte Activation Test (MAT). 

Join us for a comprehensive overview of pyrogen and endotoxin risks and detection methods.

Join our webinar to enhance your knowledge and skills in the realm of QC data integrity for endotoxin testing.

Learn about the immediate benefits of implementing PyroGene^® rFC in your lab.

Webinar attendees will learn how to increase efficiencies in the QC lab by incorporating sustainable solutions for testing, automation and digitalization.

You will learn about the responsibilities of a Contract Test Lab (CTL) and it's sponsor for pyrogen and endotoxins testing of various classes of parenteral products. Testing requirements and procedures, including how to overcome assay interferences, will be discussed.

Webinar attendees will learn what biologic products are, how they are tested for endotoxin content and how to overcome assay interferences.

This webinar describes to the customer the criticality of testing vaccines for the presence of endotoxin, and how those testing procedures are carried out.

As a leading developer, manufacturer and user of bacterial endotoxins test (BET) solutions, Lonza can fulfill your need for efficient, compliant and sustainable endotoxin testing. This webinar will discuss how automation of your BET program using the Lonza PyroTec^® PRO Robotic System, integrated with our robust WinKQCL^® Analysis and Detection Software, streamlines your testing program for the long run.

Learn about the essentials of testing medical devices for endotoxin, including updates released by the USP and the requirement for suitability testing.

Explore the new regulatory landscape for rFC and MAT as the assays gain global approval. rFC and MAT are no longer the 'alternatives'.

During this webinar we disucss the common sources of variability in endotoxin testing. Learn about product dependent and independent failures.

Learn about what LAL manufacturers are doing to help solve the Low Endotoxin Recovery (LER) mystery. 

Learn how to tackle common forms of interference associated with endotoxin detection assays, and get the latest update on LER.

Learn how to establish endotoxin limits, validate the use of the Bacterial Endotoxins Test (BET) and establish procedures for routine testing.

Learn more about the PyroGene^® rFC Assay, our animal-free method for endotoxin detection.

Learn how the MODA-EM^® Module can support digital transformation by enabling the full digitization of traditionally manual workflows.

Hear how KBI built processes for modularity and scalability in a GMP environment by transitioning away from traditional, siloed processes.

Hear from Phanesh Koneru, CEO of Exela^® Pharma Sciences, on why MES was important to him and Exela^®.

Lonza and Trakcel discuss how to deliver an integrated digital solution to support the CGT industry and ensure chain of custody and chain of identity throughout the process.

Webinar attendees will learn how to increase efficiencies in the QC lab by incorporating sustainable solutions for testing, automation and digitalization.

Join our panel of experts who discuss and share their experiences of recent MES implementations.

In this webinar, Walter Bagni shares Lonza's approach digitalizing our cell therapy manufacturing operations and the future plans for the MODA-ES^® System within Lonza.

Learn how to select and implement an electronic log solution that will replace paper and maximize your productivity.
 

Learn how Lonza collaborated with Nephron Pharmaceuticals, a leading pharmaceutical manufacturer to develop and implement the MODA-ES^® Electronic Batch Record Platform in an accelerated timeframe of 9 months.

Learn from this case study how Adaptimmune, a leader in developing T cell cancer therapies, implemented Lonza's paperless MODA^® Solution to manage information in their QC micro lab more efficiently.

See EBR as a cost-effective solution focusing on the end-user experience, workflow-driven data entry, and ability to review and approve by exception.

Learn how to integrate devices and systems in QC and production.

This webinar discusses how to build a compelling business case for implementing a Paperless QC Micro Solution.

Watch our webinar to learn how full integration of LIMS and the MODA-EM^® Solution provides benefits to pharmaceutical quality control.

During this webinar you learn how to integrate device and consumables data with your lab compliance activities using the MODA^TM Solution.

The webinar discusses how the analytical tools of the MODA^® Solution improve the speed and quality of excursion and adverse trend analysis.

Learn about regulatory expectations and data integrity in the QC Micro Lab and how they can be attained through automation.